Clinical Phase II Trial of Treosulfan in Patients with Non-Resectable Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 2296-5262|21|4|316-319

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.21, Iss.4, 1998-09, pp. : 316-319

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

EML4-ALK in non-small-cell lung cancer: the breathtaking progress from benchtop to Phase III clinical trial

By Ku Geoffrey Y   Lima Jopes Jr Gilberto de  

Therapy, Vol. 8, Iss. 1, 2011-01 ,pp. : 55-61

Future Medicine

Access to resources Recommend Favorite

Phase II Trial of Weekly Paclitaxel in Previously Untreated Advanced Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 224-228

Karger

Access to resources Recommend Favorite

High‐level expression of Hsp90β is associated with poor survival in resectable non‐small‐cell lung cancer patients

By  

HISTOPATHOLOGY, Vol. 309-0167, Iss. 4, 2015-10 ,pp. : 509-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

High‐level expression of Hsp90β is associated with poor survival in resectable non‐small‐cell lung cancer patients

By  

HISTOPATHOLOGY, Vol. 67, Iss. 4, 2015-10 ,pp. : 509-519

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is Cisplatin Required for the Treatment of Non-Small-Cell Lung Cancer? Experience and Preliminary Results of a Phase I/II Trial with Topotecan and Vinorelbine

By  

Oncology, Vol. 61, Iss. 1, 2001-09 ,pp. : 35-41

Karger

Access to resources Recommend Favorite